India's Supriya Lifescience on track for worst fall in a month on probe into official
06/07/2026 05:34
BUZZ-India's Supriya Lifescience on track for worst fall in a month on probe into official ** Supriya Lifescience SPRL.NS shares fall nearly 6% to 923.6 rupees
** Stock on track for worst intraday pct fall in over a month
** Pharmaceutical co says Customs Department is probing General Manager (Sales & Marketing) Sreekant Sreedharan under the Narcotic Drugs and Psychotropic Substances Act
** Co says probe over alleged procedural lapse in an export transaction involving an identified product; officer under judicial detention
** YTD, up to last close, stock up 25%
(Reporting by Payel Das in Bengaluru)
Recent news on Supriya Lifescience
See all newsBrief: Supriya Lifescience Says Court Orders Provisional Release Of 200 KG Ketamine Hydrochloride Consignment
Brief: Supriya Lifescience Limited Says June-Quarter Profit 240.4 Million Rupees
India's Supriya Lifescience on track for worst fall in a month on probe into official
Brief: Supriya Lifescience Says Lote Facility Receives USFDA EIR With Voluntary Action Indicated Classification
India's Supriya Lifescience rises on higher quarterly profit